Navigation Links
Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents
Date:7/7/2008

HONG KONG, July 7 /PRNewswire/ -- OrbusNeich today announced that data presented recently at the 17th Annual Meeting of the Japanese Society of Interventional Cardiology demonstrate that the Genous Bio-engineered R stent has better outcomes when compared to drug-eluting stents.

Presented by Federico Piscione, M.D., the study's principal investigator and a professor with the Federico II University of Naples's Division of Cardiology, Department of Clinical Medicine and Cardiovascular Sciences, the data were generated following a study that involved 257 consecutive high-risk patients who underwent percutaneous coronary intervention with either the Genous stent or a TAXUS(R) and CYPHER(R) stent at the university's catheterization lab.

At 13 months clinical follow-up, the cumulative MACE rate for the Genous (GRS) group was 17.2% versus 26.4% for the combined TAXUS and CYPHER group (DES), a 35% reduction. For the MACE components, the rate of myocardial infarction (MI) was 4.5% for GRS versus 6.8% for DES, the re-percutaneous coronary intervention (Re-PCI) was 7.5% for GRS and 13.5% for DES, and the cardiac death rate was 4.5% for GRS versus 7.4% for DES. In addition, the rate for stent thrombosis was 0% for GRS versus 5.8% for DES.

"Our results suggest that the Genous Bio-engineered R stent is safe and effective in high-risk patients," said Piscione. "The results show a better long-term clinical outcome when compared with DES."

After PCI, patients who received GRS were prescribed dual-antiplatelet therapy for one month, and patients who received DES were prescribed the same therapy for 12 months. A complete clinical follow-up was obtained in 100% of GRS patients vs. 96% of DES patients.

Additionally, 22 consecutive patients requiring "life saving", undeferrable major noncardiac surgery (NCS) or endovascular aortic repair (EVAR), underwent coronary angiography for clinical or instrumental signs of ischemia before NCS or EVAR and we
'/>"/>

SOURCE OrbusNeich
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
2. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
3. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
4. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
5. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
6. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
9. New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis
10. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... and TORONTO , Aug. ... (OTCQB: GNBT) today announced the issuance of a white ... proprietary buccal insulin spray product.  The white paper was ... the Company,s stockholders by Dr. James H. Anderson, ... white paper may be viewed online on the Generex ...
(Date:8/27/2015)... Pa. , Aug. 27, 2015  PinnacleHealth CardioVascular Institute ... and second in the United States ... new type of stent for blockages in the main artery ... within the artery and potentially less risk for stent fracture ... is a prospective, single-arm, multicenter clinical trial of the BioMimics ...
(Date:8/27/2015)... , August 27, 2015 ... Persistence Market Research titled "Global Market Study on ... Growth by 2021", the urinary catheters market is expected to ... of 2015. It is anticipated to expand at ... reach US$1,755.0 Mn by 2021. View ...
Breaking Medicine Technology:Generex Announces Issuance of Buccal Insulin White Paper 2Generex Announces Issuance of Buccal Insulin White Paper 3Generex Announces Issuance of Buccal Insulin White Paper 4First Pennsylvania Patient Treated in Landmark Vascular Study 2Global Urinary Catheters Market Will Reach US$1,755.0 Mn by 2021: Persistence Market Research 2Global Urinary Catheters Market Will Reach US$1,755.0 Mn by 2021: Persistence Market Research 3Global Urinary Catheters Market Will Reach US$1,755.0 Mn by 2021: Persistence Market Research 4
... MILFORD, Mass., Nov. 14, 2011 PLC Systems Inc. ... technologies, today reported financial results for the three and ... only include the company,s RenalGuard® operations, since PLC completed ... Novadaq Corp. during the first quarter of 2011. Results ...
... (Nasdaq CM: INSM), a biopharmaceutical company, announced today that Timothy ... corporate overview at the Lazard Capital Markets 8th Annual Healthcare ... in New York. A live audio webcast ... webcast will also be archived for 90 days. ...
Cached Medicine Technology:PLC Systems Reports Third Quarter 2011 Results 2PLC Systems Reports Third Quarter 2011 Results 3PLC Systems Reports Third Quarter 2011 Results 4PLC Systems Reports Third Quarter 2011 Results 5PLC Systems Reports Third Quarter 2011 Results 6Insmed to Present at Lazard Capital Markets 8th Annual Healthcare Conference 2
(Date:8/27/2015)... La Mirada, CA (PRWEB) , ... August 27, 2015 , ... ... Accreditation Agency, into its La Tijera Clinic in Los Angeles. Licensed to practice Chinese ... with an emphasis on neuromuscular injuries and diseases. Dr. Priebe also practices in Healthpointe’s ...
(Date:8/27/2015)... (PRWEB) , ... August 27, 2015 , ... More destinations ... a road trip. That’s why Amica Insurance is sharing some tips to help your ... America, about 30 million people travel with pets each year. Amica is sharing the ...
(Date:8/27/2015)... ... August 27, 2015 , ... Banc Intranets recently entered into ... will enable both Johnson City, Tenn.-based firms to work synergistically to promote similar products ... product that caters to organizations in the financial, commercial and services sectors. The software, ...
(Date:8/27/2015)... , ... August 27, 2015 , ... ... high-performance blending all in one machine with the Nutri Ninja® Auto-iQ Pro Complete ... next-generation Auto-iQ™ Smooth Boost™ Technology that takes drink customization to a whole new ...
(Date:8/27/2015)... ... 2015 , ... Florida Hospital North Pinellas, located at 1395 South Pinellas Avenue in Tarpon Springs, ... new facility will be located at US Highway 19 North and Highlands Boulevard, less than ... and work on the project is slated to begin in September 2015. , ...
Breaking Medicine News(10 mins):Health News:Qualified Medical Examiner and Acupuncturist Joins Healthpointe in Los Angeles 2Health News:Qualified Medical Examiner and Acupuncturist Joins Healthpointe in Los Angeles 3Health News:Amica Unleashes 5 Tips for Safe Traveling with Pets 2Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 2Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 3Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 4Health News:SharkNinja's Nutri Ninja® Auto-iQ™ Pro Complete Delivers Power And Versatility In A Compact Design 2Health News:SharkNinja's Nutri Ninja® Auto-iQ™ Pro Complete Delivers Power And Versatility In A Compact Design 3Health News:SharkNinja's Nutri Ninja® Auto-iQ™ Pro Complete Delivers Power And Versatility In A Compact Design 4Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 2Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 3
... older adults with one of two classes of available drugs ... yearly flu shots are likely a better bet. // ... caring for older adults with the flu or a flu-like ... for flu before treatment with an anti-flu drug, and treating ...
... new study finds whole grains, fruits and vegetables will decrease ... dying. However, the study also reports these foods do not ... Dietary Guidelines for Americans include choosing a variety of fruits ... especially whole grains. While at least five fruits and vegetables ...
... lung cancer before it's in a more advanced stage is ... //can detect early lung cancer, researchers wanted to determine if ... researchers who wanted to look at the cost-effectiveness of a ... part of the Early Lung Cancer Action Project (ELCAP) that ...
... the drug dalteparin is beneficial for diabetic patients with severe ... for diabetic patients and are one of the most expensive ... limb of the diabetic patient. A new study led by ... of the drug dalteparin on foot ulcers in diabetic patients. ...
... they've developed a new way to treat certain kinds ... that emits far more high-energy radioactivity than current radio-isotopes ... tumor cells invade bone marrow. For many years, doctors ... with bone metastases. ,The radio-isotopes ease pain by ...
... vascular dementia find it can help treat the cognitive ... or VaD -- is usually associated with cardiovascular disease. ... of dementia are attributed to VaD. Unlike Alzheimer’s disease, ... time, VaD often strikes quickly, such as after a ...
Cached Medicine News:
... The Infinity Uric Acid single liquid ... the convenience of single liquid stability ... operator error and provide quick result ... the Infinity Uric Acid reagent provides ...
... The Infinity Glucose Oxidase single ... all the convenience of single liquid ... minimize operator error and provide quick ... of the Infinity Glucose Oxidase reagent ...
... single liquid stable reagent offers the ... liquid stability to help maximize laboratory ... quick result turnaround time. The proprietary ... provides a long shelf life that ...
... the profitability of your practice by seeing more ... VELO system you can turn a 14-18 patients ... day practice. By streamlining automated test sequences, youll ... technology is simple to learn; making it easy ...
Medicine Products: